# Trip.com Group Limited

Type: Company (TCOM)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/tripcom-group-limited
Canonical HTML page: https://getfinancebrief.com/entity/tripcom-group-limited

## Timeline

- **2026-05-11**: Lead Plaintiff Deadline — Final date for affected investors to petition the court to lead the litigation.
- **2026-03-22**: Lawsuit Publicized — Kessler Topaz informs investors of the filed securities fraud class action.
- **2026-01-13**: Class Period Ends — Likely date of a corrective disclosure or regulatory event that impacted stock price.
- **2024-04-30**: Class Period Begins — Start of the period during which Trip.com allegedly made misleading statements.

## Recent coverage (2 stories)

### Trip.com Group Faces Securities Fraud Lawsuit Over Alleged Monopolistic Conduct
2026-03-23 01:01:38 · Sentiment: Bearish · Impact: 6/10 · Sources: 2

Trip.com Group Limited is the subject of a class-action lawsuit alleging material misstatements regarding its business practices and monopolistic activities between April 2024 and January 2026. Investors who suffered losses have until May 11, 2026, to seek lead plaintiff status in the litigation filed in the Eastern District of New York.
Full story: https://getfinancebrief.com/story/trip-com-group-securities-fraud-lawsuit-monopolistic-practices

### Pomerantz Law Firm Issues Litigation Deadlines for TCOM, AQST, and DRVN
2026-03-13 02:09:36 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz Law Firm has issued urgent reminders for investors regarding class action lawsuits against Trip.com Group, Aquestive Therapeutics, and Driven Brands Holdings. These legal actions focus on alleged securities violations and material misrepresentations that resulted in significant shareholder losses.
Full story: https://getfinancebrief.com/story/pomerantz-law-firm-investor-alerts-tcom-aqst-drvn

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.